|
⚲
|
| China Aoxing Pharmaceutical Company Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001060426 |
| Sale | 2009-08-06 ($5.0 M Offered, $5.0 M Sold) |
| Fund | |
| Phone | 6463671747 |
| Address | 15 Exchange Place, Suite 500 Jersey City, 07302 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Zhenjiang Yue | |
| John Oshea | |
| Jun Min | |
| Howard Sterling | |
| Guozhu Xu | |
| Hui Shao |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
MBX Capital II-A, LP
✚
|
0.0 | |
|
McBeath Kathryn
✚
|
0.0 | |
|
McCabe Peter David
✚
|
0.0 | |
|
McCafferty Terence M.
✚
|
0.0 | |
|
McCann Corey
✚
|
0.0 | |
|
McCormick Michael W
✚
|
0.0 | |
|
McCourt Martin
✚
|
0.0 | |
|
McCoy Sarah Gaines
✚
|
0.0 | |
|
McCree Douglas I.
✚
|
0.0 | |
|
MBV R2G REIT LLC
✚
|
0.0 |